Sionna Therapeutics, Inc.
SION
$37.17
-$0.15-0.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.98% | 20.29% | -111.27% | -39.12% | -33.45% |
| Total Depreciation and Amortization | -8.98% | 11.83% | -11.45% | -4.22% | 3.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 418.85% | -67.68% | 504.47% | 83.66% | -33.22% |
| Change in Net Operating Assets | -109.63% | 220.80% | -13.18% | 26.53% | 0.55% |
| Cash from Operations | -41.13% | 13.89% | -78.94% | -23.63% | -58.09% |
| Capital Expenditure | -655.56% | -- | -- | -- | 77.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.41% | 122.82% | 18.78% | -13.86% | 110.41% |
| Cash from Investing | 48.33% | 121.99% | 18.78% | -13.93% | 113.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,536.00% | 2,604.11% | -- | 4,047,680.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 217.83% | 298.19% | -921.05% | 11.61% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 273.76% | 218.98% | -7.70% | 1.53% | 729.32% |